– The FDA has granted the company’s rapid immunoassay test Emergency Use Authorization. According to the company, it is licensed for use in laboratories with a CLIA waiver license and produces results in 15 minutes.
– The Biomedical Advanced Research and Development Authority (“BARDA”) has awarded the company a $12.7 million contract to build a rapid SARS-CoV-2 antigen test system for use at point-of-care during the forthcoming flu season.
Chembio Diagnostics Inc(CEMI) is a stock of interest due to the large impact the company has on the market. Here at Wall Street Facts we only cover the best stocks so make sure you check out our other articles. Today we will be diving deep into all of the essential information you need to know about CEMI. We will be studying the movement so you can make the best decision as an investor. The stock has moved upwards today by 67.69%. The high for today is 6.04 and today’s low is 5.02. This information is critical in deciding whether this investment is risky or not. We can see the stock is trending upwards, which means the volume of people buying this stock is greater than people selling it.
Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases; handheld analyzers; and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Hauppauge, NY.
As an investor, you can get an idea of where the stock is trending by the forecast. In this case, the high forecast for Chembio Diagnostics Inc is $13.00 and the low forecast is $9.50. We can get a look into the future by looking at past trends. Looking at Chembio Diagnostics Inc’s 5-year movement it seems it has fallen 4.4%. Overall, Chembio Diagnostics Inc is in great shape going forward. They have a strong market cap of $118.87M and a very bright future ahead of them.